2,4-diaminobutyric acid has been researched along with Leukemia L 1210 in 1 studies
2,4-diaminobutyric acid: RN given refers to parent cpd without isomeric designation
2,4-diaminobutyric acid : A diamino acid that is butyric acid in which a hydrogen at position 2 and a hydrogen at position 4 are replaced by amino groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosowsky, A | 1 |
| Freisheim, JH | 1 |
| Moran, RG | 1 |
| Solan, VC | 1 |
| Bader, H | 1 |
| Wright, JE | 1 |
| Radike-Smith, M | 1 |
1 other study available for 2,4-diaminobutyric acid and Leukemia L 1210
| Article | Year |
|---|---|
Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
Topics: Aminobutyrates; Aminopterin; Animals; beta-Alanine; Cell Division; Folic Acid Antagonists; Glutamate | 1986 |